Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Neutrophilia, lymphocytosis and reactive leucocytosis

Haematology and transfusion · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

A very high white count with dyspnoea, hypoxia, confusion, focal neurology, retinal change or priapism can indicate leukostasis in acute leukaemia and requires immediate haematology and critical-care involvement. Do not assume sepsis and give large fluid loads blindly. Blasts, promyelocytes with coagulopathy, tumour-lysis biochemistry or haemodynamic sepsis each activate their own urgent pathway.

Synopsis

Interpret raised white-cell counts by lineage, time course and morphology, recognise reactive physiological and infective patterns, and escalate blasts, clonal lymphocytosis or unexplained persistence appropriately.

  • Leucocytosis is a laboratory description; classify the absolute neutrophil, lymphocyte, monocyte, eosinophil and basophil counts rather than interpreting the total alone.
  • Neutrophilia commonly accompanies bacterial infection, inflammation, tissue necrosis, corticosteroids, smoking, pregnancy, G-CSF, stress and splenectomy.
  • Reactive lymphocytosis is common in viral infection and can show large activated lymphocytes; pertussis and some bacterial or parasitic infections also raise lymphocytes.
  • Corticosteroids cause neutrophil demargination with lymphopenia and eosinopenia, often without the left shift or toxic change expected in intense bacterial inflammation.
  • A blood film can identify toxic granulation, Döhle bodies, reactive lymphocytes, blasts, dysplasia, smudge artefact and immature myeloid cells and is central to triage.
  • Basophilia, persistent myeloid left shift and splenomegaly raise chronic myeloid leukaemia and warrant BCR::ABL1 testing through haematology.
  • Persistent clonal-appearing lymphocytosis, lymphadenopathy, splenomegaly, cytopenias or B symptoms prompts flow cytometry and a lymphoproliferative pathway.
  • Repeat a clinically plausible reactive count after recovery because trajectory often separates transient response from a persistent clonal process.
  • Leukaemoid reactions can reach striking counts in severe infection, inflammation or growth-factor exposure, but magnitude alone cannot reliably distinguish them from myeloid neoplasia.
  • Treat the underlying cause rather than the number in uncomplicated reactive leucocytosis; cytoreduction is reserved for specialist malignant or hyperviscosity indications.

Key red flags

Leukostasis syndrome

New hypoxia, confusion, focal neurology or retinal disturbance with suspected acute leukaemia requires emergency cytoreduction planning.

Investigation priorities

01
Repeat full count with differentialFirst step

Confirm lineage, persistence and associated cytopenias.

Management branches

TriageFind malignant danger before explaining the count

A raised white-cell count is accompanied by systemic or haematological symptoms.

  1. Assess breathing, neurology, retina, bleeding, infection and spleen and review haemoglobin, platelets, film flags, coagulation and tumour-lysis markers.
  2. Call haematology immediately for blasts, promyelocyte concern, leukostasis physiology, major cytopenias or tumour lysis and avoid delaying definitive sampling.
  3. Treat sepsis and other physiological emergencies in parallel, recognising that infection and leukaemia can coexist.

Key medicines

No medicine for an uncomplicated reactive countDo not prescribe cytoreduction or antimicrobial treatment solely for the white-cell number; treat a clinically defined infection, inflammation or exposure using its own regimen.A reactive hypothesis requires follow-up to resolution; persistent, basophilic, blast-containing or symptomatic leucocytosis still needs haematology assessment.
Emergency cytoreductionA haematologist selects hydroxycarbamide, leukapheresis or disease-specific induction according to leukaemia subtype, symptoms, count kinetics and tumour-lysis risk.Do not begin empirically without preserving diagnostic samples and specialist direction; anticipate tumour lysis, cytopenias, infection and reproductive implications.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE suspected cancer recommendationsReferral for unexplained abnormal counts, lymphadenopathy, splenomegaly and leukaemia features.
  • British Society for Haematology lymphocytosis guidelineFilm, flow cytometry and classification of clonal lymphocytosis.
  • NHS genomic test directory BCR ABL1NHS molecular testing route for suspected myeloid neoplasia.
  • BNF systemic corticosteroid guidanceSystemic steroid effects, infection risk and monitoring context.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom